Participation ahead for medical technology industry in first UK "safety solutions"
This article was originally published in Clinica
Executive Summary
Drafts of the first two sets of guidelines of a UK "patient safety solutions" programme were issued yesterday for open consultation. The measures proposed for "preventing ventilator-associated pneumonia" and "improving medicines reconciliation at admission" do not have explicit medtech-related implications, but the initiative does provide device suppliers with a platform for, at the very least, airing the benefits of their products.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.